RSV vaccines are being underutilized among older US adults, a group at high risk for severe cases. The extent to which certain populations, such as veterans, are affected by low uptake is not entirely clear, but disparities are reported to exist. Studies suggest that RSV vaccines can be highly effective in protecting older adults, although the level of protection may vary over time.